Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 9 Sarcoma 8 Breast 5 Thoracic 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 268 Carboplatin 264 Cisplatin 194 Bevacizumab 136 pembrolizumab 99 Surveys and Questionnaires 84 Radiotherapy 77 Cyclophosphamide 75 olaparib 67 Blood Specimen Collection 65 Drug Therapy 62 Hyperthermic Intraperitoneal Chemotherapy 60 Gemcitabine 60 niraparib 56 Topotecan 56 Brachytherapy 54 liposomal doxorubicin 52 Taxes 47 Docetaxel 46 Magnetic Resonance Spectroscopy 44 Letrozole 36 Cytoreduction Surgical Procedures 36 Filgrastim 33 Biopsy 33 Surgical Procedures, Operative 32 Specimen Handling 32 durvalumab 31 Doxorubicin 31 Nivolumab 30 Albumin-Bound Paclitaxel 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × talimogene laherparepvec × Gynecologic × Clear all

NCT03663712 2024-11-20

TEMPO

Duke University

Phase 1 Completed

28 enrolled 10 charts

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡